FDA.reportPublic FDA data

DAYVIGO 10 MG Oral Tablet

RxCUI
2288427
RxNorm name
DAYVIGO 10 MG Oral Tablet
Display name
DAYVIGO 10 MG Oral Tablet
Full name
DAYVIGO 10 MG Oral Tablet
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:03

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
DAYVIGOLEMBOREXANTEisai Inc.7074cb65-77b3-45d2-8e8d-da8dc0f70bfd2025-02-24Warnings, Adverse reactionsExact identifier
rxcui: 2288427

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
7074cb65-77b3-45d2-8e8d-da8dc0f70bfdDAYVIGO 10 MG Oral Tablet [PSN] · lemborexant 10 MG Oral Tablet [Dayvigo] [SBD] · Dayvigo 10 MG Oral Tablet [SY]339These highlights do not include all the information needed to use DAYVIGO ® safely and effectively. See full prescribing information for DAYVIGO ® . DAYVIGO ® (lemborexant) tablets, for oral use, CIV Initial U.S. Approval: 201920250224